| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TESARO INC | 1,248,086 | 167,843,000 | 27.84% | ||
| 2 | ACCELERATE DIAGNOSTICS INC | 5,032,389 | 104,422,000 | 17.32% | ||
| 3 | NXSTAGE MED INC COM | 2,721,636 | 71,334,000 | 11.83% | ||
| 4 | MAZOR ROBOTICS LTD | 2,719,942 | 59,621,000 | 9.89% | ||
| 5 | QUIDEL CORP COM | 2,517,554 | 53,926,000 | 8.94% | ||
| 6 | OPKO HEALTH INC | 3,534,539 | 32,871,000 | 5.45% | ||
| 7 | AMARIN CORP PLC | 7,935,000 | 24,440,000 | 4.05% | ||
| 8 | PACIFIC BIOSCIENCES CALIF IN | 5,516,894 | 20,964,000 | 3.48% | ||
| 9 | BIOLASE INC | 14,622,050 | 20,471,000 | 3.40% | ||
| 10 | INTREXON CORP | 820,590 | 19,940,000 | 3.31% | ||
| 11 | VERMILLION INC | 8,624,225 | 8,193,000 | 1.36% | ||
| 12 | AGENUS INC | 1,925,918 | 7,935,000 | 1.32% | ||
| 13 | ACCURAY INCORPORATED COM | 1,490,879 | 6,858,000 | 1.14% | ||
| 14 | CONTRAFECT CORP COM | 1,182,032 | 2,069,000 | 0.34% | ||
| 15 | BIOGEN INC | 6,723 | 1,907,000 | 0.32% | ||
| 16 | SECOND SIGHT MED PRODS INC COM | 50,804 | 100,000 | 0.02% | ||
| 17 | ZIOPHARM ONCOLOGY INC | 6,661 | 36,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-17-000784, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
